Levocarnitine for the Treatment of Polymorbid Patients
Effective and safe treatment of patients with polymorbidity is an urgent task of modern healthcare. Of particular difficulty is the treatment of patients with cardiovascular comorbidity, which requires an integrated approach to the treatment and development of a special, so-called patient-oriented a...
Saved in:
| Main Authors: | A. P. Pereverzev, D. A. Shevchenko, A. V. Filippova, A. A. Kirichenko, I. F. Krotkova, O. D. Ostroumova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2020-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2134 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
POLYMORBIDITY: SPECIFICS OF CO-DEVELOPMENT AND CONCOMITANCE OF SEVERAL DISEASES IN ONE PATIENT
by: R. G. Oganov, et al.
Published: (2016-08-01) -
The Effect of Levocarnitine on Dynamics of the Brain Bioelectrical Activity Formation in Term Infants Delivered by Cesarean Section: Open Randomized Study Results
by: Tatiana S. Tumaevа, et al.
Published: (2017-06-01) -
The polymorbidity in dermatology: late diagnosis and consequences
by: M. M. Tlish, et al.
Published: (2021-06-01) -
Features of polymorbid pathology in patients with autoimmune bullous dermatosis
by: M. A. Ufimtseva, et al.
Published: (2021-01-01) -
C-reactive protein as an indicator of polymorbidity in patients with arterial hypertension
by: E. V. Sevostyanova, et al.
Published: (2022-04-01)